Quality Assurance
Every Lot. Every Time.
Our quality program is built on a simple principle: a provider ordering peptide APIs for research should never have to wonder about purity, provenance, or documentation. Here is how we deliver on that.
cGMP Manufacturing
All peptide APIs are manufactured in the United States under current Good Manufacturing Practice (cGMP) standards. Our manufacturing partner maintains rigorous process controls, environmental monitoring, and documentation protocols in compliance with FDA 21 CFR Parts 210 and 211.
API Certification
Our supplier holds Active Pharmaceutical Ingredient certification, meeting the quality and safety standards required for API-grade raw materials. This certification covers identity, purity, potency, and composition testing at every stage of production.
Third-Party Testing
Every production lot undergoes independent third-party testing before release. Testing includes identity confirmation, purity analysis (HPLC), endotoxin screening, microbial limits, and heavy metals testing. Results are documented in a Certificate of Analysis (COA) available to verified purchasers.
Made in America
Peptide APIs are synthesized and quality-tested within the United States. Domestic manufacturing eliminates supply chain opacity, reduces transit degradation risk, and ensures compliance with US regulatory standards throughout the production process.
Nationwide Shipping
We ship to licensed providers in all 50 states. Products are packaged under controlled conditions with appropriate cold-chain handling where required. Shipping protocols are designed to maintain product integrity from our facility to your practice.
Certificates of Analysis
Every lot ships with a third-party Certificate of Analysis (COA) documenting identity, purity, potency, endotoxin levels, microbial limits, and heavy metals content. Registered providers can access COAs for any product directly through the provider portal.
Register to View COAsResearch Foundation
Manufacturer R&D
Our 503A + 503B dual-licensed manufacturer maintains an in-house R&D program for peptide formulation and lyophilization technique. Process improvements roll into production through documented change-controlled procedures — every lot carries the same COA standards regardless of formulation refinement.
Questions About Our Quality Program?
We are happy to discuss manufacturing, testing, or documentation in detail.